Last Posted: Sep 14, 2018
- Huge genetic-screening effort helps pinpoint roots of breast cancer Scientists have sifted through thousands of genetic sequences in search of those that could foster tumours.
H Ledford, Nature, September 12, 2018 - High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan.
Yamauchi Hideko et al. Breast cancer research and treatment 2018 Sep - Poly (ADP-ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: A Drug Class Review.
Ringley J Tanner et al. P & T : a peer-reviewed journal for formulary management 2018 Sep 43(9) 549-556 - A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.
de Souza Timoteo Ana Rafaela et al. Breast cancer research and treatment 2018 Aug - Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma.
Gleeson Ferga C et al. Current treatment options in gastroenterology 2018 Sep - Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Li Jingmei et al. International journal of cancer 2018 Sep - Surgery for BRCA , TP53 and PALB2: a literature review.
Song Chin-Vern et al. Ecancermedicalscience 2018 12863 - Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.
Gilbert Elizabeth et al. Annals of surgical oncology 2017 Oct 24(10) 3048-3054 - Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.
Abdel-Razeq Hikmat et al. BMC cancer 2018 18(1) 152 - Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System.
Marino Maria Adele et al. European journal of radiology 2018 Sep 106150-159
.png)
No hay comentarios:
Publicar un comentario